Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 25, 2024

SELL
$47.98 - $54.4 $172,008 - $195,024
-3,585 Reduced 43.36%
4,683 $253,000
Q4 2023

Feb 12, 2024

SELL
$48.48 - $57.85 $294,806 - $351,785
-6,081 Reduced 42.38%
8,268 $424,000
Q3 2023

Nov 09, 2023

SELL
$57.89 - $64.73 $34,270 - $38,320
-592 Reduced 3.96%
14,349 $832,000
Q2 2023

Aug 07, 2023

BUY
$63.71 - $70.74 $117,990 - $131,010
1,852 Added 14.15%
14,941 $955,000
Q1 2023

May 10, 2023

SELL
$65.71 - $74.53 $62,358 - $70,728
-949 Reduced 6.76%
13,089 $907,000
Q4 2022

Jan 27, 2023

SELL
$68.48 - $81.09 $173,528 - $205,482
-2,534 Reduced 15.29%
14,038 $0
Q3 2022

Oct 31, 2022

SELL
$0.13 - $76.84 $27 - $16,520
-215 Reduced 1.28%
16,572 $1.18 Million
Q2 2022

Jul 27, 2022

SELL
$72.62 - $79.98 $15,395 - $16,955
-212 Reduced 1.25%
16,787 $1.29 Million
Q1 2022

May 05, 2022

SELL
$61.48 - $73.72 $50,536 - $60,597
-822 Reduced 4.61%
16,999 $1.24 Million
Q4 2021

Feb 10, 2022

BUY
$53.63 - $62.52 $5,202 - $6,064
97 Added 0.55%
17,821 $1.11 Million
Q3 2021

Nov 04, 2021

SELL
$59.17 - $69.31 $5,857 - $6,861
-99 Reduced 0.56%
17,724 $1.05 Million
Q2 2021

Aug 02, 2021

SELL
$61.91 - $67.42 $15,910 - $17,326
-257 Reduced 1.42%
17,823 $1.19 Million
Q1 2021

May 05, 2021

SELL
$59.34 - $66.74 $109,719 - $123,402
-1,849 Reduced 9.28%
18,080 $1.14 Million
Q4 2020

Feb 04, 2021

SELL
$57.74 - $65.43 $60,165 - $68,178
-1,042 Reduced 4.97%
19,929 $1.24 Million
Q3 2020

Oct 27, 2020

SELL
$57.43 - $63.64 $18,894 - $20,937
-329 Reduced 1.54%
20,971 $1.26 Million
Q2 2020

Jul 22, 2020

SELL
$54.82 - $64.09 $27,245 - $31,852
-497 Reduced 2.28%
21,300 $1.25 Million
Q1 2020

Apr 22, 2020

SELL
$46.4 - $67.43 $138,968 - $201,952
-2,995 Reduced 12.08%
21,797 $1.22 Million
Q4 2019

Feb 07, 2020

BUY
$49.21 - $64.19 $20,520 - $26,767
417 Added 1.71%
24,792 $1.59 Million
Q3 2019

Nov 07, 2019

BUY
$42.77 - $50.71 $17,492 - $20,740
409 Added 1.71%
24,375 $1.24 Million
Q2 2019

Aug 16, 2019

BUY
$44.62 - $49.34 $90,980 - $100,604
2,039 Added 9.3%
23,966 $1.09 Million
Q1 2019

May 14, 2019

SELL
$45.12 - $53.8 $30,636 - $36,530
-679 Reduced 3.0%
21,927 $1.05 Million
Q4 2018

Feb 14, 2019

BUY
$48.76 - $63.23 $1.1 Million - $1.43 Million
22,606 New
22,606 $1.18 Million

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $125B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Human Investing LLC Portfolio

Follow Human Investing LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Human Investing LLC, based on Form 13F filings with the SEC.

News

Stay updated on Human Investing LLC with notifications on news.